Anticolchicine cytotoxicity enhanced by Dan Gua-Fang, a Chinese herb prescription in ECV304 in mediums

Chinese Journal of Integrative Medicine

Volumn 17, Issue 2, 2011, Pages 126-133

  Heng, Xian Pei ^a,b   Chen, Ke Ji ^b,c   Hong, Zhen Feng ^a   He, Wei Dong ^c   Chu, Ke Dan ^a   Chen, Wen Lie ^c   Zheng, Hai Xia ^a   Yang, Liu Qing ^a   Chen, Ling ^a   Guo, Fang ^a  

^a FUJIAN UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^b INSTITUTE OF CHINESE MATERIA MEDICA   (China)

^c Fujian Academy of Integrative Medicine   (China)

Author keywords

Colchicine; Dan Gua Fang; Diabetes mellitus; Endothelial cell

Indexed keywords

CHINESE DRUG; COLCHICINE; DAN GUA FANG; GLUCOSE; UNCLASSIFIED DRUG;

ARTICLE; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; CULTURE MEDIUM; CYTOSKELETON; CYTOTOXICITY; HEART PROTECTION; HUMAN; HUMAN CELL; HYPERGLYCEMIA; PRIORITY JOURNAL; UMBILICAL VEIN ENDOTHELIAL CELL;

CELL CULTURE TECHNIQUES; CELL LINE; CELL SHAPE; COLCHICINE; CULTURE MEDIA; CYTOPROTECTION; CYTOTOXINS; DRUG ANTAGONISM; DRUG COMBINATIONS; DRUG EVALUATION, PRECLINICAL; DRUG SYNERGISM; DRUGS, CHINESE HERBAL; ENDOTHELIAL CELLS; GLUCOSE; HUMANS; UMBILICAL VEINS; UP-REGULATION;

EID: 79952562338     PISSN: 16720415     EISSN: 19930402     Source Type: Journal    
DOI: 10.1007/s11655-011-0646-X     Document Type: Article

References (12)

1. Heng XP, Chen KJ. Diabetic intensive treatment and blood vascular complication. Chin J Integr Tradit West Med (Chin) 2008;28:563-566.
2. Heng XP, ed. Differential treatment of diabetic microvascular complications. 1st ed. Beijing: People's Medical Publishing House; 2002:55-58.
3. Heng XP, Chen KJ, Hong ZF, He WD, Cu KD, Chen WL, et al. Glucose endothelial cytotoxicity and protection of Dan Gua-Fang, a Chinese herb prescription in HUVEC in hyperglycemia medium. J Diabetes Complicat 2009;23:297-303.
4. HAPO Study Cooperative Research Group, Metzger BE, Lowe LP, Dyer AR, Trimble ER, Chaovarindr U, Coustan DR, et al. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 2008;358:1991-2002. (Pubitemid 351656454)
5. Liu XP, Luo CY, Cao RX, Liu JH, Wen F, Li Y, et al. High glucose induced vascular endothelial growth factor expression via protein kinase C pathway in human umbilical vein endothelial cells in vitro. Chin J Arterioscler (Chin) 2006;14:17-20.
6. Duffy A, Liew A, O'Sullivan J, Avalos G, Samali A, O'Brien T. Distinct effects of high-glucose conditions on endothelial cells of macrovascular and microvascular origins. Endothelium 2006;13:9-16.
7. Ezquer FE, Ezquer ME, Parrau DB, Carpio D, Yañez AJ, Conget PA. Systemic administration of multipotent mesenchymal stromal cells reverts hyperglycemia and prevents nephropathy in type 1 diabetic mice. Biol Blood Marrow Transplant 2008;4:631-640.
8. Luppi P, Cifarelli V, Tse H, Piganelli J, Trucco M, Luppi P, et al. Human C-peptide antagonises high glucose-induced endothelial dysfunction through the nuclear factor-kappaB pathway. Diabetologia 2008;51:1534-1543.
9. Huang WY, Sun H, Pan XQ, Fei L, Guo M, Bao HY, et al. Effects of colchicine on synthesis and excretion of cytokines and extracellular matrix by human renal fibroblasts. Chin J Pediatr (Chin) 2004;42:524-527.
10. Kovács P, Csaba G. Effect of drugs affecting microtubular assembly on microtubules, phospholipid synthesis and physiological indices (signalling, growth, motility and phagocytosis) in tetrahymena pyriformis. Cell Biochem Funct 2006;24:419-429. (Pubitemid 44379581)
11. Golestaneh N, Klein C, Valamanesh F, Suarez G, Agarwal MK, Mirshahi M. Mineralocorticoid receptor-mediated signaling regulates the ion gated sodium channel in vascular endothelial cells and requires an intact cytoskeleton. Biochem Biophys Res Commun 2001;280:1300-1306. (Pubitemid 32917785)
12. Heng XP. Strategies and methods for the treatment of diabetic neuropathy using integrative Chinese and Western medicine. Chin J Integr Med 2008;14:245-247.